David Westenberg
Stock Analyst at Piper Sandler
(3.58)
# 791
Out of 4,847 analysts
176
Total ratings
46.6%
Success rate
6.15%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintains: Neutral | $55 → $70 | $63.47 | +10.29% | 4 | May 15, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $2 → $1.25 | $0.99 | +26.57% | 8 | May 15, 2025 | |
| NTRA Natera | Maintains: Overweight | $205 → $210 | $160.69 | +30.69% | 15 | May 15, 2025 | |
| ILMN Illumina | Maintains: Overweight | $190 → $185 | $81.09 | +128.14% | 16 | May 15, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $205 → $210 | $169.42 | +23.95% | 14 | May 12, 2025 | |
| LH Labcorp Holdings | Maintains: Neutral | $260 → $280 | $247.85 | +12.97% | 4 | May 6, 2025 | |
| NEO NeoGenomics | Maintains: Overweight | $18 → $12 | $7.17 | +67.36% | 9 | May 6, 2025 | |
| GH Guardant Health | Maintains: Overweight | $50 → $60 | $42.10 | +42.52% | 9 | May 6, 2025 | |
| FLGT Fulgent Genetics | Maintains: Neutral | $16 → $23 | $20.67 | +11.27% | 8 | May 6, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Overweight | $11 → $13 | $9.55 | +36.13% | 13 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $200 | $174.40 | +14.68% | 7 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.4 → $5 | $5.69 | -12.13% | 12 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.4 → $1.65 | $1.25 | +32.00% | 8 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $12 | $13.42 | -10.58% | 9 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8.5 → $8 | $2.83 | +183.19% | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $70 | $56.13 | +24.71% | 10 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $435 → $510 | $514.80 | -0.93% | 10 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $3 | $3.13 | -4.15% | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $9.45 | - | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $29.65 | - | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $46.73 | - | 1 | Nov 21, 2017 | |
Tempus AI
May 15, 2025
Maintains: Neutral
Price Target: $55 → $70
Current: $63.47
Upside: +10.29%
Pacific Biosciences of California
May 15, 2025
Maintains: Neutral
Price Target: $2 → $1.25
Current: $0.99
Upside: +26.57%
Natera
May 15, 2025
Maintains: Overweight
Price Target: $205 → $210
Current: $160.69
Upside: +30.69%
Illumina
May 15, 2025
Maintains: Overweight
Price Target: $190 → $185
Current: $81.09
Upside: +128.14%
Zoetis
May 12, 2025
Maintains: Overweight
Price Target: $205 → $210
Current: $169.42
Upside: +23.95%
Labcorp Holdings
May 6, 2025
Maintains: Neutral
Price Target: $260 → $280
Current: $247.85
Upside: +12.97%
NeoGenomics
May 6, 2025
Maintains: Overweight
Price Target: $18 → $12
Current: $7.17
Upside: +67.36%
Guardant Health
May 6, 2025
Maintains: Overweight
Price Target: $50 → $60
Current: $42.10
Upside: +42.52%
Fulgent Genetics
May 6, 2025
Maintains: Neutral
Price Target: $16 → $23
Current: $20.67
Upside: +11.27%
Adaptive Biotechnologies
May 6, 2025
Maintains: Overweight
Price Target: $11 → $13
Current: $9.55
Upside: +36.13%
Apr 28, 2025
Maintains: Neutral
Price Target: $180 → $200
Current: $174.40
Upside: +14.68%
Apr 22, 2025
Maintains: Neutral
Price Target: $6.4 → $5
Current: $5.69
Upside: -12.13%
Apr 14, 2025
Maintains: Neutral
Price Target: $2.4 → $1.65
Current: $1.25
Upside: +32.00%
Mar 6, 2025
Maintains: Neutral
Price Target: $16 → $12
Current: $13.42
Upside: -10.58%
Mar 4, 2025
Maintains: Overweight
Price Target: $8.5 → $8
Current: $2.83
Upside: +183.19%
Feb 26, 2025
Maintains: Overweight
Price Target: $75 → $70
Current: $56.13
Upside: +24.71%
Feb 10, 2025
Maintains: Neutral
Price Target: $435 → $510
Current: $514.80
Upside: -0.93%
Nov 13, 2023
Maintains: Neutral
Price Target: $3.5 → $3
Current: $3.13
Upside: -4.15%
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $9.45
Upside: -
Jan 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $29.65
Upside: -
Nov 21, 2017
Initiates: Neutral
Price Target: n/a
Current: $46.73
Upside: -